controls (Fig. 4) . The mice did not lose significant weight and did not show any gross abnormalities upon necropsy at the end of the treatment. In a parallel experiment, doxorubicin administered intravenously at its maximal tolerated dose of 10 mg/kg inhibited the growth of SJSA-1 xenografts by 81%.
Inhibition of MDM2 expression by antisense oligonucleotides has recently been shown to activate p53 and suppress tumor growth in mouse xenograft models (18, 19) . However, this approach targeted the expression of the protein and could not distinguish between p53-dependent and p53-independent mechanisms because tumor cells with mutant p53 also responded to the treatment both in vitro and in vivo. The small-molecule inhibitors of MDM2-p53 interaction reported here have shown p53-dependent activity in multiple cellular models, strongly implying that their antitumor mechanism is derived from activation of the p53 pathway. However, the in vivo activity of the Nutlins may not be limited to tumor tissues. Our preliminary evidence suggests that p53 activation may affect xenograft growth by more than one mechanism, including effects on the tumor microenvironment (25) . Although our data strengthen the notion that unleashing the powerful growth suppressive and proapoptotic activity of p53 by MDM2 antagonists is a potentially valuable strategy for treating cancer, further studies are needed to address the true therapeutic potential of the approach. This strategy may be applicable not only to tumors with aberrant MDM2 expression but also to tumors that have retained wild-type p53. 817 (1993 . The loss of TGF-␤ responsiveness in fibroblasts resulted in intraepithelial neoplasia in prostate and invasive squamous cell carcinoma of the forestomach, both associated with an increased abundance of stromal cells. Activation of paracrine hepatocyte growth factor (HGF) signaling was identified as one possible mechanism for stimulation of epithelial proliferation. Thus, TGF-␤ signaling in fibroblasts modulates the growth and oncogenic potential of adjacent epithelia in selected tissues.
W. El-Deiry et al., Cell 75,
Epithelial-mesenchymal interactions play a critical role in development and cancer progression. In addition to the mesenchymal cell regulation of germ layers during organogenesis, tissue fibroblasts regulate the proliferation and differentiation of epithelial tissues (1, 2) . Transformed stroma can induce malignancy in lung and mammary epithelia (3, 4) , and conversely, normal fibroblasts have been reported to convert malignant epithelia in the prostate and skin to morphologically benign lesions (5, 6) . Known mediators of epithelial-mesenchymal interaction include members of the TGF-␤ family (7) (8) (9) . This family is responsible for context-dependent inhibition or stimulation of cell proliferation and neoplastic transformation (10) (11) (12) . TGF-␤ exerts its effect by binding the TGF-␤ type II receptor (T␤RII) and subsequently recruiting the type I receptor (T␤RI) for downstream cytoplasmic signaling through multiple parallel signaling pathways, including the Smad proteins (13) .
To study the role of TGF-␤ signaling in stromal fibroblasts in vivo, we generated mice conditionally inactive for Tgfbr2, the gene encoding T␤RII. Tgfbr2
mice, having loxP sites at introns 1 and 2 of Tgfbr2 (14) , were crossed with mice expressing Cre recombinase under the control of the FSP1 (fibroblast specific protein-1; S100A4) promoter [(15); fig S1] . FSP1 is selectively expressed in fibroblasts (16, 17) during development after embryonic day 8.5 (18) . In mice expressing green fluorescent protein (GFP) under the control of the FSP1 promoter, FSP.GFP (16), FSP1-expressing fibroblasts were seen in the interstitial stroma of mature tissues throughout the mouse, including the prostate, forestomach, and skin ( fig.  S1 ). Selective Cre-mediated recombination within the prostate and forestomach stromal fibroblasts were observed in FSP.CreRosa26r mice (15, 19) (fig. S1 ). We did not observe any phenotypic differences between the Tgfbr2 floxE2/floxE2 and Tgfbr2 fspKO (homozygous knockout) tissues examined, including the skin, esophagus, lung, kidney, and liver ( fig. S2 ). However, the male Tgfbr2 fspKO mice were sterile, and both males and females died at about 8 weeks of age. Thus, the bigenic line was propagated by backcrossing Tgfbr2
wt/fspKO (heterozygous knockout) mice to C57BL/6 Tgfbr2 floxE2/ floxE2 mice, and the experiments described below were done with F 6 and F 7 generation mice in the C57BL/6 strain.
We determined whether FSP1. Tgfbr2 wt/fspKO mice, possibly the result of a loss of positive-feedback stimulation. The lack of TGF-␤ binding to T␤RIII in cultured keratinocytes has been reported previously (20) .
By 3 weeks of age, Tgfbr2 fspKO male mice displayed an abundance of stromal fibroblasts lacking T␤RII and nuclear phosphorylated Smad2 in the anterior, dorsolateral, and ventral prostate lobes. In contrast, almost all of the sparse stromal fibroblasts from wild-type and Tgfbr2 floxE2/floxE2 animals demonstrated T␤RII expression and phosphorylated Smad2 in the nucleus (Fig. 1, A and B; fig. S3 ). The Tgfbr2 fspKO stromal phenotype was accompanied by epithelial hyperplasia and foci of hyperchromatic nuclei with atypia, suggestive of intraepithelial neoplasia (100% of 32 Tgfbr2 fspKO mice examined). This developed by 5 to 7 weeks of age and occurred predominantly in the anterior and dorsolateral prostate lobes (Fig. 1, A and B S4; Fig. 1, C and D) . A high percentage of the abundant stromal cells lacked nuclear phosphorylated Smad2 staining, which provided additional evidence for abrogation of TGF-␤ littermates (n ϭ 12; Fig. 1, E and F) . Thus, as a result of the loss of TGF-␤ signaling in fibroblasts, fibroblast and luminal epithelial proliferation was increased and was associated with the development of preneoplastic lesions in the prostate epithelia.
Seven-week-old Tgfbr2 fspKO mice consistently exhibited invasive squamous cell carcinoma of the forestomach that resulted in a significant decrease in stomach volume (100% of 12 Tgfbr2 fspKO mice examined; fig.   S5 ) (Fig. 2, A and B forestomach. Immunostaining for T␤RII and phosphorylated Smad2 corroborated these findings; a high percentage of the abundant Tgfbr2 fspKO stromal cells lacked T␤RII expression and nuclear phosphorylated Smad2 staining, as evidence for abrogation of TGF-␤ signaling due to recombination of Tgfbr2 (Fig. 2, C and D; fig. S4 ).
All Tgfbr2 fspKO forestomach squamous cell carcinomas invaded into the fundus and stomach body by 7 weeks of age. There was a general loss of parietal cells in the glandular prostate. In contrast, the Tgfbr2 fspKO prostate epithelia is hyperplastic with nuclear atypia (arrowhead), and the accompanying abundant stroma (asterisk) appear activated based on the significant cytoplasmic to nuclear ratio. (C and D) Nuclear immunostaining of activated phosphorylated Smad2 was observed in Tgfbr2 fspKO and Tgfbr2 floxE2/floxE2 epithelia (arrowheads). Although Tgfbr2 floxE2/floxE2 prostate fibroblasts stained for phosphorylated Smad2, most Tgfbr2 fspKO fibroblasts lacked such staining (asterisk). (E and F) Elevated nuclear Ki-67 expression was observed in the epithelia (arrowheads) and fibroblasts (asterisks) of Tgfbr2 fspKO mice compared with the infrequent staining in Tgfbr2 floxE2/floxE2 mice. Scale bar represents 500 m and 250 m for the insets. stomach in Tgfbr2 fspKO mice, associated with decreased acidity of the stomach contents (pH 5.5-7.0, compared with pH 3.0 in Tgfbr2 floxE2/floxE2 mice). Examination of Tgfbr2 fspKO forestomach at 2 and 10 days postnatally revealed no abnormalities, which suggested that forestomach development does not require stromal TGF-␤ signaling and indicated that the carcinoma evolved rapidly in the mice between 2 and 7 weeks of age. The minimal monocytic infiltration in the stomach submucosa observed in Tgfbr2 fspKO mice might be due to loss in the integrity of the epithelial lining (21) . The stomach tumors, coupled with disruption of the stomach lining, were most likely the cause of death in the Tgfbr2 fspKO mice by 8 weeks of age. As deduced from Ki-67 staining, the proliferation in the forestomach was limited to the basal cells in Tgfbr2 floxE2/floxE2 mice. However, areas associated with spontaneous squamous cell carcinoma in 7-week-old Tgfbr2 fspKO mice exhibited a fourfold increase in the proliferation of fibroblasts and squamous carcinoma cells in the forestomach that invade into the stomach body (n ϭ 8, Fig. 2, E and F) . Together, these data indicate that TGF-␤ signaling in fibroblasts not only limits fibroblast proliferation in vivo, but can also inhibit the proliferation of adjacent epithelial cells in a tissue-specific manner.
To investigate possible mechanisms underlying the development of neoplasia in the Tgfbr2 fspKO mice, we performed Western blot analyses of prostate and forestomach tissue extracts. The expression level of TGF-␤1 was comparable in the Tgfbr2
floxE2/floxE2
and Tgfbr2 fspKO mice (Fig. 3A, table S1 ). By contrast, the expression level of the transcription factor often elevated in transformed cells, c-Myc (22), was higher in Tgfbr2 fspKO forestomach and prostate tissues than in Tgfbr2 floxE2/floxE2 mice (Fig. 3A, table S1 ). Because the physiology and cellular composition of mouse forestomach is comparable to human esophagus, we evaluated the expression of prognostic markers and paracrine factors implicated in esophageal carcinoma. The Tgfbr2 fspKO forestomach samples exhibited diminished expression of the cdk inhibitors, p21 and p27, compared with Tgfbr2 floxE2/ floxE2 controls. Similar comparisons in the prostate showed decreased expression of p27 in the Tgfbr2 fspKO mice, but similar p21 expression (Fig. 3A, table S1 ). We further studied the signaling by two mitogenic growth factors known to be regulated by TGF-␤, hepatocyte growth factor (HGF), and epidermal growth factor (EGF/TGF-␣). Western blots for activated EGF receptor-1 did not exhibit any consistent pattern in the Tgfbr2 fspKO and Tgfbr2 floxE2/floxE2 forestomach. However, Western blotting for the phosphorylated c-Met (activated HGF receptor), showed a more than twofold increased abundance in Tgfbr2 fspKO forestomachs examined compared with Tgfbr2 floxE2/floxE2 littermates (Fig. 3A, table S1 ). Total levels of c-Met were not significantly different in Tgfbr2 floxE2/floxE2 and Tgfbr2 fspKO forestomach tissues. Western and enzyme-linked immunosorbent assay (ELISA) analysis was used to further examine HGF expression. The inactive pro-HGF expression in the forestomach tissue extracts in Tgfbr2 fspKO mice were almost 2 times that in Tgfbr2 floxE2/floxE2 mice, with no significant differences in the prostate tissues (Fig. 3B, table S1 ). However, the medium of conditioned primary fibroblast cultures demonstrated that Tgfbr2 fspKO fibroblasts from both forestomach and prostate secreted at least 3 times as much active-HGF as Tgfbr2 floxE2/floxE2 fibroblasts (Fig. 3C ), which indicated a paracrine mechanism for activation of c-Met.
To localize phosphorylated c-Met and cMyc overexpression, we immunostained adjacent sections of prostate and forestomach ( fig. S6 ). Proliferating basal cells of the prostate and forestomach from Tgfbr2 S6 ). In light of evidence suggesting that TGF-␤ inhibits HGF expression (23) , the loss of TGF-␤ signaling in stromal fibroblasts may in fact result in HGF-mediated cell-cycle regulation by suppressing cyclin-dependent kinase inhibitors, p27 and p21, as well as induction of c-Myc (24, 25) .
In conclusion, we provide evidence that TGF-␤ signaling in fibroblasts differentially affects epithelial growth and oncogenesis. Despite the striking phenotypic changes in the prostate and forestomach, many other tissues appeared histologically normal ( fig.  S2 ). Because FSP1.Cre-mediated T␤RII recombination in fibroblasts occurs after embryonic day 8.5 (18) , when commitment to organogenesis is complete in many tissues, our mouse model implicates a role for stromal TGF-␤ signaling in tissue maturation. The conservation of structure and function within the TGF-␤ family of proteins, including bone morphogenetic proteins and activin, which mediate their actions through receptors other than T␤RII (13), likely resulted in functional compensation for TGF-␤ loss in most tissues and may have masked other roles of stromal signaling.
Previous studies have indicated that stromal cells influence the carcinogenesis process in adjacent epithelia (2-7), but the specific paracrine factors and signaling pathways involved have not been identified. The Tgfbr2 fspKO mouse model illustrates that a signaling pathway known to suppress cell-cycle progression when activated in epithelial cells can also have an indirect inhibitory effect on epithelial proliferation when activated in adjacent stromal fibroblasts in vivo. Loss of this inhib- (ϩ/ϩ) and Tgfbr2 fspKO (ko) mice were analyzed for the expression of the indicated proteins by Western blotting. Phospho-specific antibodies for EGF receptor and c-Met were used to evaluate the activated forms of these receptor proteins. The Western blots were quantified from extracts of at least three independent mice and normalized to ␣-tubulin, loading control (table S1). (B) HGF (90 kD, pro-HGF) expression from tissue lysates was blotted with actin as the loading control (table S1; n ϭ 4). (C) Conditioned media from primary cultures of forestomach and prostate fibroblasts were analyzed for the expression of active HGF by ELISA assay (n ϭ 7; error bars, SD; P value determined from unpaired two-tailed Student's t test).
itory effect can result in increased epithelial proliferation and may even progress to invasive carcinoma in some tissues
